J&J receives FDA warning, issues recall
The agency says sales of 2 orthopedic products violated federal rules.
By Andrea Tse, TheStreet
The products in question are the TruMatch Personalized Solutions System, a knee replacement device, and the Corail Hip System.
"A review of our records reveals that you have not obtained marketing approval or clearance before you began offering the TruMatch Personalized Solutions System for sale," the FDA said in the letter to J&J. The agency said the Corail Hip System was also being marketed for "unapproved uses."
Both products are being sold by J&J's DePuy Orthopaedics unit.
The FDA has asked DePuy Orthopaedics to "immediately cease marketing the Corail Hip System for unapproved uses" and said it will evaluate the information J&J submits for TruMatch to determine whether the product may be legally marketed.
This week, it was also reported that J&J, which has in the past recalled popular products such as Tylenol, recalled millions of disposable 1-Day Acuvue contact lenses in Asia and Europe.
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
New study finds members of this global elite are stashing an average $600 million each in cash -- 10 times more than a year ago.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.